A possible chemopreventive role for photodynamic therapy in Gorlin syndrome: A report of basal cell carcinoma reduction and review of literature

Australasian Journal of Dermatology

Volumn 54, Issue 1, 2013, Pages 64-68

  Wolfe, Christopher M ^a   Green, W Harris ^b   Cognetta Jr , Armand B ^b   Hatfield, H Keith ^b  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b Dermatology Associates of Tallahassee   (United States)

Author keywords

basal cell carcinoma; chemoprevention; Gorlin's syndrome; naevoid basal cell carcinoma syndrome; photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; CELECOXIB; IMIQUIMOD;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CASE REPORT; CHEMOPROPHYLAXIS; EVIDENCE BASED PRACTICE; FEMALE; HOSPITAL PATIENT; HUMAN; MEDICAL LITERATURE; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; RED LIGHT; TREATMENT DURATION; UPPER LIP;

BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 84873407656     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2012.00922.x     Document Type: Article

References (18)

1. Oseroff AR, Shieh S, Frawley NP, et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch. Dermatol. 2005; 141: 60-67.
2. Itkin A, Gilchrest B,. A. delta-aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol. Surg. 2004; 30: 1054-1061.
3. Chapas AM, Gilchrest BA,. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome. J. Drugs Dermatol. 2006; 5 (2 Suppl): 3-5.
4. Gilchrest BA, Brightman LA, Thiele JJ, et al. Photodynamic therapy for patients with basal cell nevus syndrome. Dermatol. Surg. 2009; 35: 1576-1581.
5. Pauwels C, Mazereeuw-Hautier J, Basset-Seguin N, et al. Topical methyl aminolevulinate photodynamic therapy for management of basal cell carcinomas in patients with basal cell nevus syndrome improves patient's satisfaction and reduces the need for surgical procedures. J. Eur. Acad. Dermatol. Venereol. 2011; 25: 861-864.
6. Mougel F, Debarbieux S, Ronger-Savle S, et al. Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy. Dermatology 2009; 219: 138-142.
7. Dijkstra AT, Majoie IM, van, Dongen JW, et al. Photodynamic therapy with violet light and topical delta-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J. Eur. Acad. Dermatol. Venereol. 2001; 15: 550-554.
8. Segura S, Puig S, Carrera C, et al. Non-invasive management of non-melanoma skin cancer in patients with cancer predisposition genodermatosis: a role for confocal microscopy and photodynamic therapy. J. Eur. Acad. Dermatol. Venereol. 2011; 25: 819-827.
9. Loncaster JA, Moore JV, Allan D, et al. An ultrasound analysis of the response of Gorlin syndrome-related and sporadic basal cell carcinomas to aminolaevulinic acid photodynamic therapy. Photodiagn. Photodyn. Ther. 2005; 2: 149-155.
10. Loncaster J, Swindell R, Slevin F, et al. Efficacy of photodynamic therapy as a treatment for Gorlin syndrome-related basal cell carcinomas. Clin. Oncol. (R. Coll. Radiol.) 2009; 21: 502-508.
11. Caty V, Liu Y, Viau G, et al. Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice. Br. J. Dermatol. 2006; 154: 740-742.
12. Ibbotson S, Szeimies RM,. Photodynamic therapy. In:, Lim H, Honigsmann H, Hawk L, (eds). Photodermatology. New York: Informa Healthcare USA, 2007; 373.
13. Moan J, Iani V, Ma L,. Choice of proper wavelength for photochemotherapy. Proc SPIE. 1996; (2625): 544-549.
14. Ceburkov O, Gollnick H,. Photodynamic therapy in dermatology. Eur. J. Dermatol. 2000; 10: 568-575; discussion 576.
15. Morton CA, MacKie RM, Whitehurst C, et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch. Dermatol. 1998; 134: 248-249.
16. Rhodes LE, de Rie MA, Leifsdottir R, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch. Dermatol. 2007; 143: 1131-1136.
17. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J. Am. Acad. Dermatol. 2007; 56: 125-143.
18. Josefsen LB, Boyle RW,. Photodynamic Therapy and the Development of Metal-Based Photosensitisers. Met Based Drugs 2008; 2008: 276109.